These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The effect of thyrotrophin releasing hormone versus placebo in combination with basic imipramine therapy of depressive patients].
    Author: Benkert O, Lücke KH.
    Journal: Arzneimittelforschung; 1976; 26(6):1162-4. PubMed ID: 822857.
    Abstract:
    20 female and 10 male patients with a retarded-depressive syndrome received imipramine (3 X 50 mg/day) for 20 days. In a double blind study oral thyrotrophin releasing hormone (TRH) (2 X 40 mg/day) and placebo, respectively, were added for the first 2 weeks. The patients were rated with the Hamiltion-depression scale and a selfrating depression scale. But the statistical evaluation showed no difference between the imipramine/TRH and the imipramine/placebo group.
    [Abstract] [Full Text] [Related] [New Search]